文献速递糖尿病

嘌呤代谢物与肉碱生物合成中间体是2型糖尿病发病的生物标志物

Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

在瑞典两个前瞻性队列(MPP发现队列698人,其中202人随访6.3年内发生T2DM;MDC-CC复制队列3423人,其中402人随访18.2年内发生T2DM)中开展非靶向代谢组学。发现N2,N2-二甲基鸟苷(DMGU)、7-甲基鸟苷(7MG)和3-羟基三甲基赖氨酸(HTML)三种代谢物在校正传统糖尿病危险因素后仍与T2DM发病独立相关,且结果可复制。

要点

  • DMGU与T2DM风险升高最强相关(OR=1.94),β-胡萝卜素与风险降低最强相关(OR=0.60)。
  • DMGU、7MG和HTML三种代谢物在两个队列中均与T2DM发病独立相关。
  • 这些代谢物可能提示嘌呤代谢和肉碱合成通路参与T2DM发病。

核心结论

  • 在两个瑞典前瞻性队列中鉴定出DMGU、7MG和HTML三种代谢物与未来T2DM风险存在独立且可复制的关联。

研究设计与样本

  • 发现队列为Malmö预防项目(MPP)的病例队列研究,含698名代谢健康参与者,随访6.3年内202人发生T2DM。
  • 复制队列为基于人群的Malmö饮食与癌症-心血管队列(MDC-CC),N=3423,随访18.2年内402人发生T2DM。
  • 采用液相色谱-质谱联用进行非靶向代谢组学检测。

主要发现

  • 非靶向代谢组学观察到9类代谢物改变与T2DM发病相关,包括11个已鉴定代谢物。
  • DMGU与T2DM风险升高最强相关(OR=1.94;P=4.9e-10;95%CI 1.57-2.39)。
  • β-胡萝卜素与T2DM风险降低最强相关(OR=0.60;P=1.8e-4;95%CI 0.45-0.78)。
  • 校正传统糖尿病危险因素后,DMGU、7MG和HTML在MPP和MDC-CC两个队列中均与T2DM发病显著相关。

临床怎么用

  • DMGU、7MG和HTML有望作为识别T2DM高危个体的候选代谢标志物,但尚需进一步研究验证其功能联系和临床效用。

局限性

  • 研究仅基于瑞典人群,外推性需在其他人群中验证。
  • 原文指出需额外研究探讨这些代谢物与T2DM发病之间的潜在功能联系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Metabolomics has the potential to generate biomarkers that can facilitate understanding relevant pathways in the pathophysiology of type 2 diabetes (T2DM). METHODS: Nontargeted metabolomics was performed, via liquid chromatography-mass spectrometry, in a discovery case-cohort study from the Malmö Preventive Project (MPP), which consisted of 698 metabolically healthy participants, of whom 202 developed T2DM within a follow-up time of 6.3 years. Metabolites that were significantly associated with T2DM were replicated in the population-based Malmö Diet and Cancer-Cardiovascular Cohort (MDC-CC) (N = 3423), of whom 402 participants developed T2DM within a follow-up time of 18.2 years. RESULTS: Using nontargeted metabolomics, we observed alterations in nine metabolite classes to be related to incident T2DM, including 11 identified metabolites. N2,N2-dimethylguanosine (DMGU) (OR = 1.94; P = 4.9e-10; 95% CI, 1.57 to 2.39) was the metabolite most strongly associated with an increased risk, and beta-carotene (OR = 0.60; P = 1.8e-4; 95% CI, 0.45 to 0.78) was the metabolite most strongly associated with a decreased risk. Identified T2DM-associated metabolites were replicated in MDC-CC. Four metabolites were significantly associated with incident T2DM in both the MPP and the replication cohort MDC-CC, after adjustments for traditional diabetes risk factors. These included associations between three metabolites, DMGU, 7-methylguanine (7MG), and 3-hydroxytrimethyllysine (HTML), and incident T2DM. CONCLUSIONS: We used nontargeted metabolomics in two Swedish prospective cohorts comprising >4000 study participants and identified independent, replicable associations between three metabolites, DMGU, 7MG, and HTML, and future risk of T2DM. These findings warrant additional studies to investigate a potential functional connection between these metabolites and the onset of T2DM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ottosson F, Smith E, Gallo W, et al. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes. J Clin Endocrinol Metab. 2019. PMID: 31502646. doi:10.1210/jc.2019-00822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。